Dr. Rikin Mehta is an executive health professional, pharmacist and medical product attorney with extensive experience in industry, government and academics.

Currently, Dr. Mehta is the Vice President, and Head of Regulatory Affairs and Quality Assurance at Aquestive Therapeutics; a publicly-traded specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives.

Prior to his current role, Dr. Mehta was the Head of Regulatory Policy for Pfizer Consumer Health where worked to advance industry and FDA policy discussions on Rx to OTC Switch, monograph reform and dietary supplement legislation. He briefly served as the Pfizer representative on the Board of Directors for the Council for Responsible Nutrition. Prior to industry, Dr. Mehta was politically appointed as the executive public health official for the DC Department of Health (DOH) where he directed the regulatory affairs department charged with protecting and enforcing the District’s public health laws. Prior to DOH, Dr. Mehta served as the Deputy Director for the Division of Medical Policy Programs with the Office of Medical Policy at the FDA. As the Deputy, Dr. Mehta created and led the Nonprescription Safe Use Regulatory Expansion (NSURE) Initiative exploring innovative approaches for nonprescription drug products to alleviate the under-treatment of common conditions or diseases by expanding access to medications through Rx to OTC Switches. Dr. Mehta started his FDA career in CDER, Office of Compliance (OC), where he worked on the Agency’s unapproved and counterfeit drugs initiative, and supply chain security policies. 

Dr. Mehta holds a B.S., Pharm.D., J.D. and LL.M in global health law, and is an adjunct professor of law at Georgetown University Law Center where he teaches courses in health and drug laws and regulations. Dr. Mehta enjoys spending time raising his 3 gentlemen and lives in Chester, NJ.